ATR logo

APTARGROUP INC

ATRNYSE
๐Ÿ† #908 by market capEarnings Oct 29US Equity
$133.10โ–ผ $0.05 (โˆ’0.04%)
Live
1hโ€”
24hโ–ผ 0.0%
7dโ–ผ 1.9%
14dโ–ผ 0.5%
30dโ–ฒ 3.7%
1yโ–ผ 5.8%
๐ŸฆMarket Cap
$8.49B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+8.9%
Slowing
๐Ÿ“ŠGross Margin
36.1%
Healthy
๐Ÿ’ตFCF Margin
7.8%
Moderate
โš–๏ธP/S Ratio
2.2x
Cheap
Otter Score
66
Fair

Trading Snapshot

Day Range
$132.54 โ€“ $135.57
52-Week Range
$103.23 โ€“ $146.91
Volume
$4.16B
Avg Volume
$4.04B
Shares Outstanding
63.8M
Next Earnings
Sep 7, 2026

Fundamentals Snapshot

Annual Revenue
$3.78B
Last Q Revenue
$1.03B
P/E Ratio
23.5
P/S Ratio
2.2x
EPS (TTM)
$5.54
Dividend Yield
1.44%

Why Investors Own ATR

  • โœ“High-growth profile โ€” revenue up +44.0% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 74% gross margin and 14% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$3.78Bโ–ฒ +47.9% YoY
Gross Margin (TTM)
74.2%โ–ฒ +1.0% YoY
Operating Income (TTM)
$846Mโ–ฒ +47.9% YoY
Free Cash Flow (TTM)
$533Mโ–ฒ +47.9% YoY

About APTARGROUP INC

AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Fair
66/100

Analyst Ratings

โ“˜
Consensus
Buy
12 analysts
Strong Buy5
Buy5
Hold2
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates

Yahooยท7d ago

AptarGroup Q2 Earnings Beat Estimates on Pharma & Beverage Growth

ATR tops Q2 earnings and revenue estimates as pharma and beverage growth lift quarterly revenues above $1B for the first time despite margin pressure.

Yahooยท10d ago

Why AptarGroup (ATR) International Revenue Trends Deserve Your Attention

Review AptarGroup's (ATR) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

๐ŸŒŒ
Benzingaยท10d ago

Wells Fargo Maintains Overweight on AptarGroup, Raises Price Target to $155

Wells Fargo analyst Gabe Hajde maintains AptarGroup (NYSE:ATR) with a Overweight and raises the price target from $145 to $155.

Yahooยท12d ago

AptarGroup Inc (ATR) (Q2 2026) Earnings Call Highlights: Record Sales and Strategic Wins Amid ...

All three segments post growth with record quarterly revenue, but margin declines and operational challenges in beauty and closures temper the outlook.

Yahooยท12d ago

AptarGroup Q2 Earnings Call Highlights

AptarGroup (NYSE:ATR) reported second-quarter sales growth across each of its three segments and adjusted earnings per share above its guidance range, supported by stronger-than-expected performance in its Pharma business. The company also said President and CEO Stephan Tanda will retire later this

SeekingAlphaยท12d ago

AptarGroup, Inc. (ATR) Q2 2026 Earnings Call Transcript

AptarGroup, Inc. (ATR) Q2 2026 Earnings Call July 31, 2026 9:00 AM EDTCompany ParticipantsMarry Skafidas - Senior Vice President of Investor Relations &...